Index Ticks Higher Ahead of This Week’s Fed Decision | Global News Avenue

Major U.S. stock indexes rose on Monday, even if the report shows Retail sales are lower than expected In February, concerns over the economic trajectory increased.

Monday’s rise marks a start New trading week This will include the Federal Reserve policy meeting. The central banker is Broad expectations To maintain the benchmark rate at the current level, as they wait for the economic impact of changing U.S. trade policy is clearer.

The S&P 500 rose 0.6% on Monday. Dow Jones Industrial’s industrial captain climbed 0.9%, while the technology-heavy Nasdaq was 0.3%.

Stock of solar equipment manufacturer Enphase Energy (Enph) The highest daily performance in the S&P 500 index surged 9.8%. With Monday’s push, the stock recovered from a series of losses over the past week, in line with the downturn in the wider market. Last week, Enphase launched the cargo of the latest electric vehicle (EV) chargers in the European market.

Intel(INTC) Stocks rose 6.8% after the release of earnings after chipmaker naming former board members late last week Lip-bu tan is its new top executive. The semiconductor giant has gained an additional vote of confidence from regulatory filings, suggesting that the incoming CEO will buy $25 million worth of Intel stock within 30 days of taking the company.

Power Generator AES Corp. Stocks (AES) jumped 6.1%. Along with other utilities, AES has attracted investors’ attention because of its opportunity to provide power to energy-intensive data centers, and large tech companies have reportedly accounted for more than 40% of the company’s backlog. Last week, AES announced pricing as $800 million premium notes that should be paid in 2032. The company plans to transfer products from 2025 payments to repurchase notes.

incyte(Incy) Stocks fell 8.6%, with the biggest losses among the largest stocks in all S&P 500 after the pharmaceutical company released results from a phase 3 clinical trial for experimental skin care treatments. Although the goal of Incyte’s plestinib is to reduce the symptoms of dermatological compound inflammation (HS), the incidence of improvement in patients is higher than that of previous drug trials.

Discover Financial shares (DFS) In the report, U.S. Department of Justice (DOJ) officials merged the credit card issuer program with Capital One Financial’s plan (COF). Justice Department staff reportedly believe that the combination may limit competition in the secondary market. Potential regulatory resistance is a report that emerged last month that said several states could file lawsuits to block transactions. Capital One shares fell 3.8%.

Tesla (TSLA) Share analysts fell 4.8% after Lower its stock targets And reduce their forecasts for automaker vehicle delivery. Ruisui’s team pointed out that China’s demand has weakened and the problem of brand perception is a factor in the softer prospects.